Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Biomol Struct Dyn. 2021 Mar 10;40(15):7099–7113. doi: 10.1080/07391102.2021.1894986

Figure 5: Construction and refinement of the multi-epitope vaccine construct.

Figure 5:

a) Final 3D model of COVCCF after modeling with I-TASSER. b) Refined model after refinement with ModRefiner and GalaxyRefine. c) Validation of structure with ProSA-web, indicating the structural properties are in line with other proteins of similar size (Z-score −7.41). d) Ramachandran plot indicating 92.7% of residues are in favored regions, and 2 residues are in outlier regions.